Serum Autoantibodies Against Cytochrome P450 2E1 (CYP2E1) Predict Severity of Necroinflammation of Recurrent Hepatitis C

No abstract is available for this paper.

• Publication year

  2009

• Venue

  American Journal of Transplantation

• Publication date

  2009-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1600-6143.2008.02520.xPMID 19191768
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic hepatitis E virus infection in liver transplant recipients

  2008cited by this paper
• Hepatitis E virus and chronic hepatitis in organ-transplant recipients.

  2008cited by this paper
• Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus

  2008cited by this paper
• Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients.

  2007cited by this paper
• Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C.

  2007cited by this paper
• The impact of autoimmunity on hepatocytes.

  2007cited by this paper
• Cytochrome P450IID6‐specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2

  2007cited by this paper
• Role of CYP2E1 Immunoglobulin G4 Subclass Antibodies and Complement in Pathogenesis of Idiosyncratic Drug-Induced Hepatitis

  2006cited by this paper
• Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2.

  2006cited by this paper
• Progressive histological damage in liver allografts following pediatric liver transplantation

  2006cited by this paper
• HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation.

  2006cited by this paper
• Liver biopsy interpretation for causes of late liver allograft dysfunction

  2006cited by this paper
• What determines the natural history of recurrent hepatitis C after liver transplantation?

  2005cited by this paper
• LKM1 autoantibodies in chronic hepatitis C infection: A case of molecular mimicry?

  2005cited by this paper
• Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C1

  2004cited by this paper
• Recurrent Hepatitis C in Liver Allografts: Prospective Assessment of Diagnostic Accuracy, Identification of Pitfalls, and Observations About Pathogenesis

  2004cited by this paper
• Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease

  2003cited by this paper
• The role of immunosuppression in recurrence of hepatitis C

  2003cited by this paper
• Cytochrome P4502D6193–212: A New Immunodominant Epitope and Target of Virus/Self Cross-Reactivity in Liver Kidney Microsomal Autoantibody Type 1-Positive Liver Disease 1

  2003cited by this paper
• Progression of fibrosis in chronic hepatitis C.

  2003cited by this paper
• Autoimmunity and hepatitis C.

  2003cited by this paper
• Autoimmune hepatitis after liver transplantation and other lessons of self‐intolerance

  2002cited by this paper
• The association between hepatitis C infection and survival after orthotopic liver transplantation.

  2002cited by this paper
• Contribution of donor age to the recent decrease in patient survival among HCV‐infected liver transplant recipients

  2002cited by this paper
• Histology predicts cirrhotic evolution of post transplant hepatitis C

  2002cited by this paper
• Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs

  2002cited by this paper
• CONCISE REVIEW IN MECHANISMS OF DISEASE Autoimmunity After Liver Transplantation

  2002cited by this paper
• Progression of fibrosis in chronic hepatitis C in children

  2001cited by this paper
• Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders

  2000cited by this paper
• Natural history of clinically compensated hepatitis C virus–related graft cirrhosis after liver transplantation

  2000cited by this paper
• Hepatitis C

  1998cited by this paper
• Banff schema for grading liver allograft rejection: An international consensus document

  1997cited by this paper
• Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluorocarbons.

  1997cited by this paper
• Cytochromes P450 and uridine triphosphate‐glucuronosyltransferases: Model autoantigens to study drug‐induced, virus‐induced, and autoimmune liver disease

  1997cited by this paper
• Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.

  1996cited by this paper
• Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis.

  1996cited by this paper
• Enzyme-specific transport of rat liver cytochrome P450 to the Golgi apparatus.

  1996cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation

  1995cited by this paper
• Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation.

  1995cited by this paper
• Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies.

  1993cited by this paper
• Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera.

  1993cited by this paper
• Hepatitis C viral infection in liver transplant recipients

  1992cited by this paper
• LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.

  1991cited by this paper

• Identification of a Shared Cytochrome p4502E1 Epitope Found in Anesthetic Drug-Induced and Viral Hepatitis

  2018cites this paper
• CYP2E1 autoantibodies in liver diseases

  2014cites this paper
• Cytochrome P450 2E1: its clinical aspects and a brief perspective on the current research scenario.

  2013cites this paper
• Markers of Inflammation and Fibrosis in Alcoholic Hepatitis and Viral Hepatitis C

  2011cites this paper
• Biomarkers for the diagnosis of the stable kidney transplant and chronic transplant injury using the ProtoArray® technology.

  2010cites this paper
• Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: possible role for molecular mimicry.

  2010cites this paper
• Conformational anti‐cytochrome P4502E1 (CYP2E1) auto‐antibodies contribute to necro‐inflammatory injury in chronic hepatitis C

  2010cites this paper
• Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury: a review

  2010cites this paper
• Caractérisation des anticorps allo-immuns et anti-HLA en transplantation rénale : étude de leur rôle sur le devenir du greffon

  2010cites this paper